Abstract
It has long been known that maternal proteins are transported to the fetus during pregnancy. Maternal antibodies provide immunity for the newborn infant during the first six months of life. Only recently with the advent of ultrasensitive DNA detection techniques has it been established that there is bidirectional traffic of not only antibodies but also cells. The term “chimerism” is used when one individual harbors cells from another individual; “microchimerism” refers to low levels of chimerism. When cells traffic between fetus and mother during pregnancy and persist, maternal and fetal microchimerism results. Chronic graft-versus-host disease (GVHD) is a condition of chimerism that shares clinical characteristics with some autoimmune diseases. Human leukocyte antigen (HLA) class II genes are known to be important both in autoimmune disease and in GVHD. When considered together, these observations led to the hypothesis that microchimerism and HLA genes of host and nonhost cells are involved in autoimmune disease. Sources of nonhost cells include cells transferred during pregnancy (maternal and fetal), a twin or unrecognized lost twin, or a blood transfusion. By this hypothesis, women who have been pregnant have an increased risk of autoimmune disease because they have two sources of microchimerism: maternal and fetal. Studies of systemic sclerosis, primary biliary cirrhosis, Sjögren’s syndrome, pruritic eruption of pregnancy, myositis, neonatal lupus, and thyroid disease have both lent support and raised doubts about the role of microchimerism in autoimmune disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aractingi S, Berkane N, Bertheau P, et al (1998) Fetal DNA in skin of polymorphic eruptions of pregnancy. Lancet 352: 1898–1901
Arnett FC, Howard RF, Tan F, et al (1996) Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma: association with an Amerindian HLA haplotype. Arthritis Rheum 39: 1362–1370
Artlett CM, Welsh KI, Black CM, Jimenez SA (1997) Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis. Immunogenetics 47: 17–22
Artlett CM, Smith JB, Jimenez SA (1998) Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 338: 1186–1191
Artlett CM, Ramos R, Jiminez SA, Patterson K, Miller FW, Rider LG (2000a) Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Lancet 356: 2155–2156
Artlett CM, Cox LA, Jimenez SA (2000b) Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens. Arthritis Rheum 43: 1062–1067
Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA (1996) Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 93: 705–708
Bianchi DW, Farina A, Weber W, et al (2001) Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism. Am J Obstet Gynecol 184: 703–706
Christner PJ, Artlett CM, Conway RF, Jimenez SA (2000) Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride. Arthritis Rheum 43: 2598–2605
Corpechot C, Barbu V, Chazouilleres O, Poupon R (2000) Fetal microchimerism in primary biliary cirrhosis. J Hepatol 33: 696–700
De Moor G, De Bock G, Noens L, De Bie S (1988) A new case of human chimerism detected after pregnancy: 46, XY karyotype in the lymphocytes of a woman. Acta Clin Belg 43: 231–235
Evans PC, Lambert N, Maloney S, Furst DE, Moore JM, Nelson JL (1999) Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 93: 2033–2037
Fanning PA, Jonsson JR, Clouston AD, et al (2000) Detection of male DNA in the liver of female patients with primary biliary cirrhosis. J Hepatol 33: 690–695
Gelpi C, Martinez MA, Vidal S, TargoffIN, Rodriguez-Sanchez JL (1994) Autoantibodies to a transfer RNA- associated protein in a murine model of chronic graft versus host disease. J Immunol 152: 1989–1999
Gleichmann E, Van Elven EH, Van der Veen JP (1982) A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation: preferential formation of autoantibodies characteristic of SLE. Eur J Immunol 12: 152–159
Hall JM, Lingenfelter P, Adams SL, Lasser D, Hansen JA, Bean MA (1995) Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization. Blood 86: 2829–2832
Ichikawa N, Kotake S, Hakoda M, Kamatani N (2001) Microchimerism in Japanese patients with systemic sclerosis. Arthritis Rheum 44: 1226–1228
Invernizzi P, De Andreis C, Sirchia SM, et al (2000) Blood fetal microchimerism in primary biliary cirrhosis. Clin Exp Immunol 122: 418–422
Johnson KL, Nelson JL, Furst DE, et al (2001) Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis. Arthritis Rheum 44: 1848–1854
Klintschar M, Schwaiger P, Mannweiler S, Regauer S, Kleiber M (2001) Evidence of fetal microchimerism in Hashimoto’s thyroiditis. J Clin Endocrinol Metab 86: 2494–2498
Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami HO (1994) Transient increase in the risk of breast cancer after giving birth. N Engl J Med 331: 5–9
Lambert NC, Distler O, Muller-Ladner U,Tylee TS, Furst DE, Nelson JL (2000a) HLA-DQA1 *0501 is associated with diffuse systemic sclerosis in Caucasian men. Arthritis Rheum 43: 2005–2010
Lambert NC, Evans PC, Hashizumi TL, et al (2000b) Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQ A1*0501: implications in autoimmunity. J Immunol 164: 5545–5548
Lee TH, Paglieroni T, Ohto H, Holland PV, Busch MP (1999) Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood 93:3127–3139
Lo YM, Lo ES, Watson N, et al (1996) Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood 88: 4390–4395
Lo YM, Lau TK, Chan LY, Leung TN, Chang AM (2000) Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem 46: 1301–1309
Maloney S, Smith A, Furst DE, et al (1999) Microchimerism of maternal origin persists into adult life. J Clin Invest 104: 41–47
McMilin KD, Johnson RL (1993) HLA homozygosity and the risk of related-donor transfusion-associated graft-versus-host disease. Transfus Med Rev 7: 37–41
Miyashita Y, Ono M, Ueki H, Kurasawa K (2000) Y chromosome microchimerism in rheumatic autoimmune disease. Ann Rheum Dis 59: 655–656
Morrow J, Nelson J, Watts R, Isenberg D (1999) Autoimmune rheumatic disease. Oxford University Press, Oxford
Mullinax F (1993) Chimerism and autoimmunity. In: Proceedings of the Fourth ASEAN Congress of Rheumatology, Singapore, October 31 to November 4, 1993, pp 39–40
Murata H, Nakauchi H, Sumida T (1999) Microchimerism in Japanese women patients with systemic sclerosis. Lancet 354: 220–00
Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA (1993) Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 329: 466–471
Nelson JL, Furst DE, Maloney S, et al (1998) Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 351: 559–562
Nelson JL (1996) Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum 39: 191–194
Petit T, Gluckman E, Carosella E, Brossard Y, Brison O,Socie G (1995) A highly sensitive polymerase chain reaction method reveals the ubiquitous presence of maternal cells in human umbilical cord blood. Exp Hematol 23: 1601–1605
Petit T, Dommergues M, Socie G, Dumez Y, Gluckman E, Brison O (1997) Detection of maternal cells in human fetal blood during the third trimester of pregnancy using allele-specific PCR amplification. Br J Haematol 98: 767–771
Pollack MS, Kirkpatrick D, Kapoor N, Dupont B, O’Reilly RJ (1982) Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med 307: 662–666
Portanova JP, Ebling FM, Hammond WS, Hahn BH, Kotzin BL (1988) Allogeneic MHC antigen requirements for lupus-like autoantibody production and nephritis in murine graft-vs-host disease. J Immunol 141: 3370–3376
Reed A, Picnorell YJ, Harwood A, Kredich D (2000) Chimerism in children with juvenile dermatomyositis. Lancet 356: 2156–2157
Rouquette-Gally AM, Boyeldieu D, Gluckman E, Abuaf N, Combrisson A (1987) Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjogren syndrome and scleroderma. Br J Haematol 66: 4547
Rubbia-Brandt L, Philippeaux MM, Chavez S, Mentha G, Borisch B, Hadengue A (1999) FISH for Y chromosome in women with primary biliary cirrhosis: lack of evidence for leukocyte microchimerism. Hepatology 30: 821–822
Srivatsa B, Srivatsa S, Johnson KL, Samura O, Lee SL, Bianchi DW (2001) Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet 358: 2034–2038
Stevens AM, Hermes H, Nelson JL (2001a) Maternal microchimerism in neonatal lupus erythematosus(NLE) [abstract]. Arthritis Rheum 44: S160
Stevens AM, Hermes H, Tylee T, Nelson JL (2001b) Maternal microchimerism in the human thymus[abstract]. Arthritis Rheum 44: S340
Tanaka A, Lindor K, Ansari A, Gershwin ME (2000) Fetal microchimerisms in the mother: immunologic implications. Liver Transpl 6: 138–143
Thomas MR, Williamson R, Craft I, Yazdani N, Rodeck CH (1994) Y chromosome sequence DNA amplified from peripheral blood of women in early pregnancy [letter]. Lancet 343: 413–414
Toda I,Kuwana M, Tsubota K, Kawakami Y (2001) Lack of evidence for an increased microchimerism in the circulation of patients with Sjogren’s syndrome. Ann Rheum Dis 60: 248–253
Vietor HE (1998) Immunomodulation induced by intrauterine transfusions. Eur J Obstet Gynecol Reprod Biol 78: 33–35
Vietor HE, Hamel BC, van Bree SP, et al (2000) Immunological tolerance in an HLA non-identical chimeric twin. Hum Immunol 61: 190–192
Wirt DP, Brooks EG, Vaidya S, Klimpel GR, Waldmann TA, Goldblum RM (1989) Novel T-lymphocyte population in combined immunodeficiency with features of graft-versus-host disease. N Engl J Med 321: 370–374
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Wien
About this chapter
Cite this chapter
Stevens, A.M., Nelson, J.L., Lambert, N. (2003). Persistence of maternal and fetal cells in autoimmune diseases. In: Sticherling, M., Christophers, E. (eds) Treatment of Autoimmune Disorders. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6016-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6016-9_11
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7288-9
Online ISBN: 978-3-7091-6016-9
eBook Packages: Springer Book Archive